Bausch Health Companies Inc. (BHC) News
Track canonical SquawkNews coverage tagged to BHC, Bausch Health Companies Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est
Bausch Health Companies (TSX: BHC ) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.
EARNINGS | Jul 29, 2026, 08:13 PM UTC
L
BHC Bausch Health Companies Inc RESULTS: Q2, Q2 Net Income $260M, Q2 REV $2.852B, Q2 pretax profit $348M, Q2 Operating Income $740M, Q2 EPS
BHC Bausch Health Companies Inc RESULTS: Q2, Q2 Net Income $260M, Q2 REV $2.852B, Q2 pretax profit $348M, Q2 Operating Income $740M, Q2 EPS $0.68, Q2 ADJ EBITDA $1.075B, Bausch Health Companies Inc Earnings Notes:, Outlo
EARNINGS | Jul 29, 2026, 08:12 PM UTC
L
BHC Beats Q2 EPS, Sales Estimates
BHC reports Q2 EPS and sales above estimates
EARNINGS | Jul 29, 2026, 08:10 PM UTC
L
BHC - BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
BHC - BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
EARNINGS | Jul 29, 2026, 08:06 PM UTC
L
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement
Québec is the first province to list (Pr)OKEDI(MC) (ext
EQUITY | Jul 06, 2026, 11:00 AM UTC